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Hyponatremia Associated with Bupropion
Bupropion is widely used for the treatment of depressive disorder and smoking 
cessation. Hyponatremia, including a syndrome of inappropriate secretion 
of antidiuretic hormone (SIADH), is not rare complication of treatment with 
antipsychotic drugs. We report a 60-year-old man who experienced severe 
hyponatremia after a treatment with bupropion for depressive disorder for the 
first time in the Korea. 
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that he was experiencing fatigue and general weakness 
of body for 3 days. He had a history of hypertension and 
old myocardial infarction that stents were placed on May 
2009. He was also diagnosed with depressive disorder 
in psychiatry on December 2009. He had been treated 
with antidepressant agents, including escitalopram (SSRI) 
10 mg, mirtazapine (TCA) 15 mg, clonazepam 0.5 mg 
and alprazolam 0.25 mg twice per day. In addition, he 
was prescribed aspirin, clopidogrel, simvastatin and 
telmisartan for hypertension and old myocardial infarction. 
Mirtazapine was substituted with bupropion due to the 
patient gaining weight in late December 2010. About a 
week later, the patient began complaining of the symptoms 
stated above. He had no generalized edema and postural 
hypotension. His neurological signs were normal. Chest 
X-ray did not show any pathologic abnormality in both 
lungs, and his left ventricular ejection fraction was 56.2% 
Introduction
Antidepressants, including the selective serotonin 
reuptake inhibitor (SSRI) and the tricyclic antidepressants 
(TCA) often cause hyponatremia
1-5). Bupropion is an 
atypical antidepressant and smoking cessation aid. The 
drug is a non-tricyclic antidepressant and its primary 
pharmacological action is to inhibit norepinephrine-
dopamine reuptake. Although bupropion does not act as 
TCA and SSRI, there are few case reports describing how 
bupropion is associated with hyponatremia
1, 2). We present 
a case of bupropion induced hyponatremia for the first time 
in the Korea. 
Case Report
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on echocardiography. His sodium level was markedly 
decreased to 111 mgEq/L from 137 mgEq/L during 2 
months. The level of another electrolytes were potassium 
3.8 mEq/L, chloride 80 mgEq/L, uric acid 5.9 mg/dL, 
BUN 24.5 mg/dL and creatinine 1.3 mg/dL. His serum 
osmolality and urine osmolality were 240 and 598 mOsm/
kg, respectively. The level of urine sodium and urine 
potassium were 41 and 82.0 mEq/L. Arterial blood gas 
analysis revealed a pH 7.413, pCO2 35.9 mmHg, pO2 77.2 
mmHg, HCO3
– 22.5 mEq/L and 95.3% O2 Saturation. 
His thyroid function test was within normal range, T3 0.62 
ng/mL, free T4 2.00 ng/dL and TSH 0.59 ulU/mL. The 
level of plasma adrenocorticotropic hormone (ACTH) was 
29.6 pg/mL (reference range: 0–60 pg/mL). We performed 
rapid ACTH test and it showed the level of serum cortisol 
after injection of ACTH, did not increase sufficiently(from 
9.1 μg/dL to 13.0 μg/dL). However, aldosterone was 
raised up to 219 pg/mL from 45 pg/mL at basal, such as a 
pattern consistent with secondary adrenal insufficiency. 
(The psychiatric drugs were thought to be the offending 
agents and were withdrawn from the treatment. We also 
added low dose of prednisolone because of secondary 
adrenal insufficiency.) Three days later, his symptoms were 
improved and sodium level slowly increased to 128 mEq/L. 
At that time, the patient again complained of severe anxiety 
and insomnia. His medications were restarted, including 
bupropion, escitalopram, mirtazapine and alprazolam. 
Two days later, his serum sodium was decreased again 
from 128 mEq/L to 123 mEq/L. He was stopped bu-
propion immediately (which was thought to cause the 
hyponatremia) but, had not been restricted water intake. 
Two weeks after withdrawn bupropion, his serum sodium 
had returned to the normal range, which was 138 mEq/
L. It did not decrease thereafter and his symptoms began 
improving. There was no evidence of internal malignancy 
suggesting a syndrome of inappropriate secretion of 
antidiuretic hormone  (SIADH) in a brain, chest and 
abdominal computed tomography as well as tumor markers 
including alpha fetoprotein and prostate specific antigen. 
Although the level of carcinoembryonic antigen (CEA) was 
slightly elevated to 6.51 ng/mL (0–4.7), we could not find 
any cancerous lesions in colonoscopy. 
Discussion
Hyponatremia is defined as a serum level of less than 
135 mEq/L and the most common electrolyte disorder
6). 
However, hyponatremia is not rare condition following 
a treatment with SSRI and antipsychotic drugs
1-5). Case 
reports of hyponatremia associated with SSRI began 
appearing in 1989. Currently, about 50 case reports have 
appeared in print. German multicenter drug surveillance 
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7) found out that about 0.06% patients who 
took SSRI developed severe hyponatremia. However, 
in certain subgroups the incidence appears to be much 
higher. Estimates of hyponatremia associated with SSRI 
and SNRI use vary from 0.5–32%. Curiously, there are 
only few case reports published regarding bupropion 
induced hyponatremia
1, 2). Some experts have suspected 
the mechanism that serotonin plays a role in regulating 
the secretion and release of alcoholdehydrogenase 
(ADH)
7-9). Nevertheless, the exact mechanism associated 
with bupropion and hyponatremia remains unknown. 
Bupropion perhaps release ADH as usual. 
Aging is one of the most significant risk factor for 
antipsychotic agent induced hypontremia
10). Incidence rate 
ranges from 12% to 33% in the elderly population
8, 11). The 
cause of high risk in elderly patients may be altered renal 
function, increased ADH secretion, increased sensitivity 
to ADH, presence of concomitant illnesses and other 
medications that contribute to hyponatremia
10). Other 
risk factors include diuretic drug use
12), recent or current 
pneumonia, lower base line serum sodium levels and lower 
body mass index
11). Monitoring of electrolytes is indicated 
for especially the elderly patients taking SSRI and bupropion 
in this context. The serum sodium levels checked at the 
start of therapy and then weekly during the first month of 
treatment
13). If the patient develops mental status change 
including lethargy, delirium, nausea, or seizures, we should 
immediately check serum sodium levels. Symptomatic 
hyponatremia is a medical emergency requiring rapid 
correction to prevent the worsening of brain edema but, 
hyponatremia must be corrected slowly (< 10–12 mEq/L 
within the first 24 hours, and < 18 mEq/L within the first 
48 hours) to avoid osmotic myelinolysis
14). 
This patient has a history of hypertension, old myocardial 
infarction, benign prostate hypertrophy and depressive 
disorder that requires a variety of medications. At first, the 
psychiatric drugs, including SSRI and bupropion, were 
thought to be the offending agents for hyponatremia, so 
they were withdrawn from the treatment. However, the 
time course of the development of the severe hyponatremic 
episodes corresponds to begin treatment with bupropion. 
Also, after re-challenge with bupropion, the hyponatremic 
episode developed again. After stopping bupropion, the 
serum sodium concentration was normalized. We also 
added low dose of prednisolone because of secondary 
adrenal insufficiency. Although, secondary adrenal 
insufficiency could have induced hyponatremia, it does not 
lead to severe hyponatremia such as in our case, since the 
secretion of aldosterone is intact during rapid ACTH test. 
Therefore, we believe that bupropion was thought to cause 
the hyponatremia in this case. A detailed serum sodium 
levels should be checked closely follow-up in this patient. 
In conclusion, elderly patients who are taking antipsychotic 
drugs, especially bupropion, should carefully monitor their 
serum sodium levels, so could avoid any potential fatal side 
effects of bupropion induced hyponatremia.  
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